Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Enliven Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Kura Oncology Inc. June 5, 202585.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 19, 2026 | Enliven Therapeutics Inc. | Option exercise | +5,000 | $2.48 | $12,400 |
| Oct 19, 2026 | Enliven Therapeutics Inc. | Open-market sale | −5,000 | $38.47 | $192,342 |
| Sep 17, 2026 | Enliven Therapeutics Inc. | Option exercise | +5,000 | $2.48 | $12,400 |
| Sep 17, 2026 | Enliven Therapeutics Inc. | Open-market sale | −2,916 | $50.03 | $145,887 |
| Sep 17, 2026 | Enliven Therapeutics Inc. | Open-market sale | −1,844 | $50.71 | $93,509 |
| Sep 17, 2026 | Enliven Therapeutics Inc. | Open-market sale | −240 | $51.48 | $12,355 |
| Aug 17, 2026 | Enliven Therapeutics Inc. | Option exercise | +5,000 | $2.48 | $12,400 |
| Aug 17, 2026 | Enliven Therapeutics Inc. | Open-market sale | −3,900 | $58.37 | $227,643 |
| Aug 17, 2026 | Enliven Therapeutics Inc. | Open-market sale | −1,100 | $59.35 | $65,285 |
| Jul 17, 2026 | Enliven Therapeutics Inc. | Option exercise | +5,000 | $2.48 | $12,400 |
| Jul 17, 2026 | Enliven Therapeutics Inc. | Open-market sale | −231 | $50.05 | $11,562 |
| Jul 17, 2026 | Enliven Therapeutics Inc. | Open-market sale | −459 | $51.55 | $23,661 |
| Jul 17, 2026 | Enliven Therapeutics Inc. | Open-market sale | −2,063 | $52.39 | $108,081 |
| Jul 17, 2026 | Enliven Therapeutics Inc. | Open-market sale | −2,184 | $53.42 | $116,669 |
| Jul 17, 2026 | Enliven Therapeutics Inc. | Open-market sale | −63 | $53.92 | $3,397 |
Questions about Helen Louise Collins
What boards is Helen Louise Collins on?
Helen Louise Collins sits on the boards of Enliven Therapeutics Inc. and Kura Oncology Inc.
How long has Helen Louise Collins served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.